Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Effective colorectal cancer (CRC) screening relies on early identification and removal of both polypoid and non-polypoid lesions with neoplastic potential. The investigators hypothesize that an intensive training program designed to enhance both recognition and classification of lesions with neoplastic potential, will result in an increase in non-polypoid adenoma detection in addition to and independent of an increase in overall adenoma detection rates.
Our Endoscopic Quality Improvement Program (EQUIP) was a prospective educational intervention with our staff endoscopist as our study population. The investigators measured adenoma detection rates for a baseline period then randomly assigned half of the endoscopists to undergo EQUIP training. The investigators then examined baseline and post-training study adenoma detection rates (ADR's) for all endoscopist (trained and un-trained) to evaluate the impact of training.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Baseline Data collection | No Intervention | ||
| Randomization and Training Arm | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Training session | Other | Series of two training sessions after the first phase of study followed by monthly feedback. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of overall adenoma detection rate | Primary outcome measures will include overall and per patient adenoma detection rate for polypoid and non polypoid neoplastic lesions. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of total polypectomy rate | Secondary outcomes will include total polypectomy rate (hyperplastic vs. adenoma), | 1 Year |
| Measurement of colonoscopy time | Total colonoscopy time and endoscopist acceptance. Variables such as patient demographics and prep quality will be adjusted for. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael B. Wallace, MD,MPH | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | United States |
Not provided
| ID | Term |
|---|---|
| D018256 | Adenomatous Polyps |
| ID | Term |
|---|---|
| D000236 | Adenoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 Year |
| Endoscopist Acceptance | Ensdoscopist acceptance rate will be measured. Variables such as patient demographics and prep quality will be adjusted for. | 1 Year |